Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,928.00    -714.00 (-15.38%)
Bid:
3,902.00
Ask:
3,912.00
Spread: 10.00 (0.256%)
Market Cap: £14.84b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Directorate Change

15 Nov 2021 07:00

RNS Number : 2772S
Halma PLC
15 November 2021
 

Halma plc ("Halma")

 

Appointment of independent non-executive Director

Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Sharmila Nebhrajani OBE as an independent non-executive Director, effective 1 December 2021. Sharmila will also be a member of Halma's Audit, Remuneration and Nomination Committees.

 

Sharmila brings a wealth of experience gained across a variety of roles - spanning both the public and private/NGO sectors - with a particularly strong background in sustainability and health. She is currently a non-executive director at ITV plc and Severn Trent plc, and Chair of the National Institute for Health and Care Excellence (NICE).Sharmila was Chief Executive of Wilton Park (part of the Foreign and Commonwealth Office), responsible for convening international policy dialogue with governments, NGOs, policy makers and academics on topics such as global health and climate risk. Previously, she worked for the Medical Research Council, Association of Medical Research Charities and NHS Sussex. In her earlier career, she held senior positions within the BBC, Cable & Wireless plc and PwC.

Dame Louise Makin, Chair, commented: "I am delighted that Sharmila has agreed to join the Halma Board. Her diverse experience, particularly in the health and medical sector, will undoubtedly bring a fresh perspective and valuable insights to the Board."

 

There are no further details to be disclosed for Sharmila Nebhrajani under Listing Rule 9.6.13R.

 

For further information, please contact:

 

Halma plc

Andrew Williams, Group Chief Executive

+44 (0)1494 721111

Marc Ronchetti, Chief Financial Officer

Charles King, Head of Investor Relations

+44 (0)7776 685948

Clayton Hirst, Director of Corporate Affairs

+44 (0)7384 796013

 

MHP Communications

Andrew Jaques / Rachel Farrington

+44 (0)20 3128 8788

 

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

Notes

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day.

Its purpose defines the three broad market areas where it operates:

· Safety: protecting life as populations grow and protecting worker safety.

· Environment: improving food and water quality, and monitoring air pollution.

· Health: meeting rising healthcare demand as growing populations age and lifestyles change.

It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

In January 2021, Halma was named Britain's Most Admired Company by Management Today.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZMMMDZVGMZM
Date   Source Headline
21st Nov 20173:10 pmRNSDoc re. Half Yearly Report
21st Nov 20177:00 amRNSHalf-year Report
1st Nov 20177:00 amRNSAcquisition
4th Oct 20175:54 pmRNSDirector/PDMR Shareholding
28th Sep 20179:57 amRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSTrading Statement
11th Sep 201712:19 pmRNSDirector Declaration
7th Sep 20179:27 amRNSDirector Declaration
1st Sep 20175:08 pmRNSTotal Voting Rights
16th Aug 20174:02 pmRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSAcquisition
1st Aug 201710:39 amRNSTotal Voting Rights
31st Jul 201712:00 pmRNSNotice of Board Change
20th Jul 20173:57 pmRNSResult of AGM
19th Jul 20172:21 pmRNSDirector Declaration
4th Jul 20173:39 pmRNSDirector/PDMR Shareholding
3rd Jul 201711:29 amRNSTotal Voting Rights
21st Jun 20175:22 pmRNSAnnual Financial Report
13th Jun 20177:00 amRNSFinal Results
1st Jun 20173:02 pmRNSTotal Voting Rights
30th May 201711:00 amRNSNotice of Results
2nd May 20173:39 pmRNSTotal Voting Rights
6th Apr 20179:00 amRNSNotice of Board change
3rd Apr 201711:12 amRNSTotal Voting Rights
23rd Mar 20177:00 amRNSTrading Update and Audit Tender
1st Mar 201712:41 pmRNSTotal Voting Rights
13th Feb 20174:06 pmRNSHolding(s) in Company
1st Feb 201712:07 pmRNSTotal Voting Rights
9th Jan 20179:00 amRNSAcquisition of FluxData
3rd Jan 20174:02 pmRNSTotal Voting Rights
1st Dec 201611:37 amRNSTotal Voting Rights
28th Nov 20163:05 pmRNSDirector/PDMR Shareholding
24th Nov 20164:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:35 pmRNSDoc re. Half Yearly Report
22nd Nov 20167:00 amRNSHalf-year Report
1st Nov 20164:43 pmRNSTotal Voting Rights
5th Oct 20165:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20164:31 pmRNSTotal Voting Rights
29th Sep 201610:00 amRNSInvestor Event
27th Sep 20169:37 amRNSDirectorate Change
23rd Sep 20164:27 pmRNSDirectorate Change
1st Sep 20165:25 pmRNSTotal Voting Rights
22nd Aug 20163:54 pmRNSDirector/PDMR Shareholding
10th Aug 20163:26 pmRNSDirector/PDMR Shareholding
1st Aug 20169:00 amRNSTotal Voting Rights
28th Jul 20163:06 pmRNSDirector/PDMR Shareholding
21st Jul 20166:01 pmRNSResult of AGM
21st Jul 20167:00 amRNSAGM Trading Update
1st Jul 201612:58 pmRNSTotal Voting Rights
21st Jun 20162:38 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.